-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ampreloxetine Hydrochloride in Orthostatic Hypotension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ampreloxetine Hydrochloride in Orthostatic Hypotension report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ampreloxetine Hydrochloride in Orthostatic Hypotension Drug Details: Ampreloxetine HCL (TD-9855) is...
-
Company Profile
NewTheravance Biopharma Inc – Company Profile
Theravance Biopharma Inc (Theravance Biopharma) is a biopharmaceutical company that discovers, develops, and markets organ-selective medicines for the treatment of inflammation and immune system disorders and specializes in developing respiratory medicines. The company is investigating its pipeline candidates for the treatment of asthma, neurogenic orthostatic hypotension (nOH), gastrointestinal motility disorders, ulcerative colitis, heart failure, chronic kidney disease (CKD), Crohn’s disease and gastroparesis and concurrent bacteremia. Theravance Biopharma has agreements with other pharmaceutical companies and holds economic interests in potential future...
Add to Basket -
Product Insights
Net Present Value Model: Northera
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Northera Drug Details Droxidopa (Northera, DOPS)...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ampreloxetine hydrochloride
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ampreloxetine hydrochloride Drug Details Ampreloxetine HCL (TD-9855) was under development for the treatment of...